Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

AI carries the opportunity to not only complement the work of healthcare practitioners but to accelerate vaccine and drug development, improve diagnostics and preventative care and fuel discovery all ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Kennedy has pledged “radical transparency” into the scientific process. But the cancellation ... meeting that is vital to the development of effective vaccines for the next flu season is ...

The Indian Council of Medical Research (ICMR) has begun the process of development of a vaccine against the deadly and highly-pathogenic H5N1 virus, also called avian influenza. ICMR will develop ...

In a new study published in the Journal of Virology, they used a ‘targeted attenuation’ approach to make specific ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...